Avian influenza vaccines: what's all the flap?

This publication has 10 references indexed in Scilit:

• Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial
  The Lancet, 2006
• Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine
  New England Journal of Medicine, 2006
• Vaccines against Avian Influenza — A Race against Time
  New England Journal of Medicine, 2006
• Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice
  The Lancet, 2006
• Immunogenicity of Fowlpox Virus Expressing the Avian Influenza Virus H5 Gene (TROVAC AIV-H5) in Cats
  Clinical and Vaccine Immunology, 2005
• Probable Person-to-Person Transmission of Avian Influenza A (H5N1)
  New England Journal of Medicine, 2005
• Heterosubtypic Immunity against Human Influenza A Viruses, Including Recently Emerged Avian H5 and H9 Viruses, Induced by FLU–ISCOM Vaccine in Mice Requires both Cytotoxic T-Lymphocyte and Macrophage Function
  Cellular Immunology, 2001
• Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza
  The Lancet, 2001
• Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans
  Vaccine, 2001
• ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus
  Vaccine, 1999